🎉 M&A multiples are live!
Check it out!

Colgate-Palmolive Valuation Multiples

Discover revenue and EBITDA valuation multiples for Colgate-Palmolive and similar public comparables like Sarantis Group, Lavipharm, and Live Verdure.

Colgate-Palmolive Overview

About Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.


Founded

1923

HQ

United States of America
Employees

34K+

Financials

LTM Revenue $20.1B

LTM EBITDA $5.0B

EV

$84.5B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Colgate-Palmolive Financials

Colgate-Palmolive has a last 12-month revenue of $20.1B and a last 12-month EBITDA of $5.0B.

In the most recent fiscal year, Colgate-Palmolive achieved revenue of $20.1B and an EBITDA of $4.9B.

Colgate-Palmolive expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Colgate-Palmolive valuation multiples based on analyst estimates

Colgate-Palmolive P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $19.5B $20.1B XXX XXX XXX
Gross Profit $10.2B $11.3B XXX XXX XXX
Gross Margin 53% 56% XXX XXX XXX
EBITDA $4.2B $4.9B XXX XXX XXX
EBITDA Margin 22% 24% XXX XXX XXX
Net Profit $1.8B $2.3B XXX XXX XXX
Net Margin 9% 11% XXX XXX XXX
Net Debt $8.0B $7.6B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Colgate-Palmolive Stock Performance

As of April 15, 2025, Colgate-Palmolive's stock price is $95.

Colgate-Palmolive has current market cap of $77.0B, and EV of $84.5B.

See Colgate-Palmolive trading valuation data

Colgate-Palmolive Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$84.5B $77.0B XXX XXX XXX XXX $3.63

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Colgate-Palmolive Valuation Multiples

As of April 15, 2025, Colgate-Palmolive has market cap of $77.0B and EV of $84.5B.

Colgate-Palmolive's trades at 4.2x LTM EV/Revenue multiple, and 17.0x LTM EBITDA.

Analysts estimate Colgate-Palmolive's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Colgate-Palmolive and 10K+ public comps

Colgate-Palmolive Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $84.5B XXX XXX XXX
EV/Revenue 4.2x XXX XXX XXX
EV/EBITDA 17.4x XXX XXX XXX
P/E 26.7x XXX XXX XXX
P/E/Growth 4.8x XXX XXX XXX
EV/FCF 23.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Colgate-Palmolive Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Colgate-Palmolive Valuation Multiples

Colgate-Palmolive's NTM/LTM revenue growth is 1%

Colgate-Palmolive's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Colgate-Palmolive's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Colgate-Palmolive's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Colgate-Palmolive and other 10K+ public comps

Colgate-Palmolive Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 3% XXX XXX XXX XXX
EBITDA Margin 24% XXX XXX XXX XXX
EBITDA Growth 14% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 25% XXX XXX XXX XXX
Revenue per Employee $0.6M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 39% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Colgate-Palmolive Public Comps

See public comps and valuation multiples for Health & Beauty and Home Care comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Live Verdure XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Colgate-Palmolive M&A and Investment Activity

Colgate-Palmolive acquired  XXX companies to date.

Last acquisition by Colgate-Palmolive was  XXXXXXXX, XXXXX XXXXX XXXXXX . Colgate-Palmolive acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Colgate-Palmolive

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Colgate-Palmolive

When was Colgate-Palmolive founded? Colgate-Palmolive was founded in 1923.
Where is Colgate-Palmolive headquartered? Colgate-Palmolive is headquartered in United States of America.
How many employees does Colgate-Palmolive have? As of today, Colgate-Palmolive has 34K+ employees.
Who is the CEO of Colgate-Palmolive? Colgate-Palmolive's CEO is Mr. Noel R. Wallace.
Is Colgate-Palmolive publicy listed? Yes, Colgate-Palmolive is a public company listed on NYS.
What is the stock symbol of Colgate-Palmolive? Colgate-Palmolive trades under CL ticker.
When did Colgate-Palmolive go public? Colgate-Palmolive went public in 1951.
Who are competitors of Colgate-Palmolive? Similar companies to Colgate-Palmolive include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm.
What is the current market cap of Colgate-Palmolive? Colgate-Palmolive's current market cap is $77.0B
What is the current revenue of Colgate-Palmolive? Colgate-Palmolive's last 12-month revenue is $20.1B.
What is the current EBITDA of Colgate-Palmolive? Colgate-Palmolive's last 12-month EBITDA is $5.0B.
What is the current EV/Revenue multiple of Colgate-Palmolive? Current revenue multiple of Colgate-Palmolive is 4.2x.
What is the current EV/EBITDA multiple of Colgate-Palmolive? Current EBITDA multiple of Colgate-Palmolive is 17.0x.
What is the current revenue growth of Colgate-Palmolive? Colgate-Palmolive revenue growth between 2023 and 2024 was 3%.
Is Colgate-Palmolive profitable? Yes, Colgate-Palmolive is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.